Skip to content
Search

Latest Stories

Moderna boss warns against Omicron jab struggle

Existing Covid-19 inoculations will struggle against the fast-spreading Omicron variant, the head of vaccine manufacturer Moderna warned on Tuesday (November 30), as countries ramp up vaccination programmes and impose further restrictions in an effort to curb growing concern.

First reported to the World Health Organization in South Africa less than a week ago, the new strain has rapidly spread from Africa to the Pacific, and from Europe to North America as dozens of countries have announced travel restrictions.


While no deaths have yet been reported from Omicron, and it could take weeks to know how infectious and how resistant the strain may prove to vaccines, its emergence underscores how besieged the world remains by Covid-19, nearly two years after the first cases were recorded.

Stephane Bancel, the head of US vaccine manufacturer Moderna, told the Financial Times in an interview published today that data would be available on the effectiveness of vaccines in the two weeks' time, but that scientists were pessimistic.

"All the scientists I've talked to... are like 'this is not going to be good'," Bancel said, warning against a "material drop" in the effectiveness of current jabs against Omicron.

Moderna, US drugmaker Pfizer and the backers of Russian vaccine Sputnik V have all announced that they are already working on an Omicron-specific vaccine.

Scientists in South Africa said they had detected the new variant with at least 10 mutations, compared with three for Beta or two for Delta -- the strain that hit the global recovery and sent millions worldwide back into lockdown.

China warned that the fast-spreading Omicron variant would cause challenges in hosting next February's Winter Olympics in Beijing, with thousands of athletes, media and participants arriving from overseas required to enter a strict "closed-loop" bubble.

Urgent action

"I think it will definitely lead to challenges linked to prevention and control," foreign ministry spokesman Zhao Lijian said.

"But China has a lot of experience in responding to Covid-19," Zhao added. "I firmly believe the Winter Olympics will be conducted smoothly."

On Monday, US President Joe Biden said the strain was "a cause for concern, not a cause for panic," stressing that he does not foresee new lockdowns or extending travel restrictions for now.

G7 health ministers called for "urgent action" to combat the Omicron variant.

The WHO said the overall risk from Omicron was "very high" and warned that any major surge would put pressure on health systems and cause more deaths.

Omicron could slow the recovery of the US economy and labour market and heighten uncertainty over inflation, Federal Reserve Chair Jerome Powell is to tell the Senate Banking Committee on Tuesday.

Governments, particularly in western Europe, had already struggled with rapid rises in case numbers and have reintroduced mandatory mask-wearing, social-distancing measures, curfews or lockdowns -- leaving businesses fearing another grim Christmas.

Germany's outgoing Chancellor Angela Merkel was to meet remotely with her successor, Olaf Scholz, and regional leaders Tuesday on whether to toughen up restrictions to tame raging infections in the European Union's largest economy.

Germany's constitutional court has ruled that sweeping restrictions such as curfews, school closures and contact restrictions were lawful, likely to pave the way for further curbs with hospitals, already over capacity, long sounding the alarm.

Bans for unvaccinated

"Contacts must be reduced," said Germany's vice-chancellor-in-waiting Robert Habeck, calling for tougher restrictions such as banning unvaccinated people from "all public facilities" apart from essential shops.

On Tuesday, Greece said coronavirus vaccines would be compulsory for over 60s, a day after Britain said all adults would be now eligible for a third Covid jab. On Tuesday, Norway also said it would offer a booster shot to all adults before Easter, as preferable to lockdown.

And in Switzerland, ahead of what some had hoped would be a prosperous ski season, hoteliers said they were facing a wave of winter cancellations following quarantine restrictions being imposed on travellers from certain countries, including Britain.

Hotels had seen "massive cancellations of corporate events and Christmas parties," said industry group HotellerieSuisse, calling on political leaders to take steps to avoid a lockdown and to maintain financial assistance to the sector already hard hit by the pandemic.

A ministerial meeting on the World Trade Organization, which had been due to take place this week in Geneva but which was postponed due to Omicron, could now take place in early March 2022, the body said.

The first confirmed case of the Omicron variant was in South Africa on November 9, with infections spreading rapidly in the country.

Russia, which has the highest toll from the virus in Europe and which has not yet reported a case of the Omicron variant, on Tuesday recorded its lowest total new daily infections since October 15.

Kazakhstan has banned flights from December 3 to Egypt, a popular tourist destination, over Omicron.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less